“Novel biomarkers in neurological and psychiatric disorders: autoantibodies to neuronal nicotinic acetylcholine receptors“ Era-Net Neuron NicAb.
Funding source: EU / BMBF, Germany (Grant No. 01EW2012, 180,000 €).
Period: 2020-2023.

“Biomarker analysis - Oxidative stress during alcohol withdrawal“
Funding source: Funding source: Cheplapharm GmbH, Germany (Grant No. 996265 CMZ-Studie, 65,000 €).
Period: 2017-2021.

“Dimethyl fumarate add-on therapy to risperidone in acutely ill schizophrenia patients.”
Funding source: Stanley Medical Research Institute, USA (Grant No. 13TAF-1734, 466,000.00 US-$).
Period: 01.04.2014 to 31.03.2017.

“12th Psychoimmunology Expert Meeting, 06-09 March 2014.”
Funding source: Deutsche Forschungsgemeinschaft (DFG), GERMANY (DFG funding for international scientific events, Grant No. STE 2055/3-1, 18,000.00 €).

“11th Psychoimmunology Expert Meeting, 08-11 March 2012.”
Funding source: Deutsche Forschungsgemeinschaft (DFG), GERMANY (DFG funding for international scientific events, Grant No. STE 2055/2-1, 18,000.00 €).

“Unrestricted educational grant in the field of biomarker research for psychiatric disorders.”
Funding source: Psynova Neurotech Ltd, UK (110,000.00 €). Period: 01.01.2010 to 31.12.2011.

“10th Psychoimmunology Expert Meeting, 12-15 November 2009.”
Funding source: Deutsche Forschungsgemeinschaft (DFG), GERMANY (DFG funding for international scientific events, Grant No. BO 799/7-1, 12,000.00 €).

“Search for CSF and serum biomarkers for the early diagnosis of schizophrenia.”
Funding source: Stanley Medical Research Institute, USA (Subaward from S. Bahn, University of Cambridge, UK; 80,000.00 €). Period: 01.01.2008 to 30.06.2009.

“Neuroinflammation and neuropil pathology in schizophrenia and bipolar disorder: A post-mortem study.”
Funding source: Stanley Medical Research Institute, USA (Grant No. 07R-1832, 300,000.00 US-$). Period: 01.07.2007 to 30.06.2010.